Evolution of the Average Target: PharmaCorp Rx Inc.

Evolution of the Target Price: PharmaCorp Rx Inc.

Changes in Analyst Recommendations: PharmaCorp Rx Inc.

e216b7610ee37f2d295e99b1c.eLA2u9odlQ4f3b7Ko3WJwDg3pyzq8fvFSRCRGovh_7s.FMNfjLwkwWkuioeTwkzk9kgP9n2zn6KNBz3WX_GsuuoQ6FzelFine36Sjg~fc4beb5daa8ef2ff2402a93cb1f45ccd

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+33.33%
+75.15%
+65.34%
+20.39%
+38.04%
+30.66%
+37.91%
+57.33%
- - +203.98%
+28.61%
Average +59.07%
Weighted average by Cap. +61.36%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5000CAD
Average target price
0.6667CAD
Spread / Average Target
+33.33%
High Price Target
0.7000CAD
Spread / Highest target
+40.00%
Low Price Target
0.6000CAD
Spread / Lowest Target
+20.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Raymond James
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5000CAD
Average target price
0.6667CAD
Spread / Average Target
+33.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PCRX Stock
  4. Consensus PharmaCorp Rx Inc.